{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-22-005083","form_type":"8-K","ticker":"SNOA","cik":"0001367083","company_name":"Sonoma Pharmaceuticals, Inc.","filed_at":"2022-07-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.525967+00:00","generated_at":"2026-06-24T09:30:01.502555+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Sonoma Pharmaceuticals appoints CEO to board, amends exec agreements, CFO to resign amid office consolidation","bullets":["CEO Amy Trombly appointed to board effective July 22, 2022; amended employment agreement with severance of one-time base salary.","COO Bruce Thornton agreement amended; change-in-control bonus of 50% of base salary added.","CFO Jerry Dvonch resigns effective on/before Dec 31, 2022; severance of $100,000 plus COBRA and equity acceleration.","Annual bonus grants approved: $162,500 for Trombly, $150,000 for Thornton.","Company consolidating to Boulder, CO; closing Woodstock, GA office as part of cost-cutting."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-22-005083","json":"https://secwatch.observer/filing/0001683168-22-005083.json","markdown":"https://secwatch.observer/filing/0001683168-22-005083.md","text":"https://secwatch.observer/filing/0001683168-22-005083.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367083/000168316822005083/0001683168-22-005083-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367083/000168316822005083/snoa_i8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T09:30:01.502555+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5fbfef8867","claim":"Jerry Dvonch resigned as Chief Financial Officer at Sonoma Pharmaceuticals, Inc..","evidence_excerpt":"In connection with the Woodstock office closure, Mr. Jerry Dvonch resigned as our Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316822005083/0001683168-22-005083-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"702c96968f","claim":"Amy Trombly was appointed as Director at Sonoma Pharmaceuticals, Inc..","evidence_excerpt":"Effective July 22, 2022, the Company’s Board of Directors appointed Amy Trombly, our Chief Executive Officer, to serve as a member of our Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316822005083/0001683168-22-005083-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}